Clinical Trials Logo

Clinical Trial Summary

This is a randomized, prospective clinical trial to determine the effects of two different pacemaker atrioventricular delay (AV delay) settings on heart function in patients with dual chamber pacemakers implanted for symptomatic bradycardia with long PR intervals (delayed conduction between upper and lower chambers of the heart). The study will compare a long, fixed AV delay (standard) with an optimized AV delay for each individual using echocardiography (experimental).


Clinical Trial Description

Cardiac pacing is the only effective treatment for symptomatic sinus node dysfunction. Most patients with preserved left ventricular function receive dual chamber pacemakers; however, right ventricular pacing can have detrimental effects on left ventricular function due to the abnormal electrical and mechanical activation pattern of the ventricles. Many patients receiving dual chamber pacemakers for symptomatic bradycardia have prolonged intrinsic AV conduction (first degree AV block), and as a result, will receive a significant amount of ventricular pacing if programmed at physiologic AV intervals. As an alternative, many pacemakers can be programmed to minimize ventricular pacing at the expense of allowing longer AV delays. However, these long AV delays may not be physiologic and may also lead to reduced cardiac output. At present the standard of care is either to program the pacemaker at an physiologic "natural" AV delay of about 160 msec or to program the pacemaker with a long AV delay to minimize ventricular pacing. The main scientific questions being addressed in this study are to evaluate the acute and chronic effects on cardiac output, functional status, sense of well-being, and cardiac remodeling of a long AV delay allowing for intrinsic conduction as compared to an echocardiographically optimized AV delay during dual chamber pacing. Patients enrolled in the trial will complete a run-in period of two weeks prior to randomization in which pacemakers will be programmed with a long-fixed AV delay to allow intrinsic conduction and minimize ventricular pacing (standard). At two weeks, patients will receive a baseline echocardiogram. To determine optimal AV delay, all patients will undergo echocardiographic analysis at varying AV delays. Optimal AV delay will be defined as the AV delay associated with the largest average aortic Doppler velocity time integral (VTI). Then, patients will be randomized to either the short, optimized (experimental) or long, fixed (standard) AV delay groups. To assess functional status and sense of well-being, patients will complete a six minute walk test and Short Form-36 Medical Outcomes Study Questionnaire. Patients return to clinic for another study visit at 6 months and repeat research procedures, including baseline echocardiogram, questionnaire, and 6 minute walk test. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02154750
Study type Interventional
Source University of California, San Diego
Contact
Status Completed
Phase N/A
Start date June 1, 2013
Completion date December 31, 2021

See also
  Status Clinical Trial Phase
Completed NCT05067114 - Solutions for Atrial Fibrillation Edvocacy (SAFE)
Completed NCT02241252 - Using an iPhone ECG to Monitor the QT Interval on Dofetilide and Sotalol Patients N/A
Completed NCT01428778 - Berlin Beat of Running Study N/A
Completed NCT01626261 - Examination of Implant´s Safety in an Electronic and Magnetic Field Environment
Withdrawn NCT01359683 - Heart Rate Variability Changes During Cardiac Surgery And The Incidence Of Post-Operative Cardiac Arrhythmias N/A
Recruiting NCT04154982 - N-Acetylcysteine Protection Against Radiation Induced Cellular Damage Phase 2
Completed NCT04609683 - Measuring Hydration Levels of Healthy and Heart Failure Patients Before, During, and After an Electrophysiology (EP) Procedure N/A
Completed NCT04162249 - High Radiofrequency Power for Faster and Safer Pulmonary Veins Isolation - a Pilot Observational Study.
Withdrawn NCT05084391 - Phase I/II Randomized Study of Stereotactic Ablative Radiotherapy (SABR) Versus Standard of Care for Refractory Structural Cardiac Arrhythmias (SABR-HEART) Phase 1/Phase 2
Completed NCT03260244 - EnSite Precision Observational Study
Recruiting NCT04474418 - Psychometric Characterization of Patients With Cardiac Arrhythmias
Recruiting NCT03996954 - Validation of a Smartphone-based Recorder for Detection of Cardiac Arrhythmias N/A
Recruiting NCT05508880 - SIGIL: Signal Interpretation and Analysis In Real Life Cardiac Arrhythmias
Terminated NCT04552665 - Prospective Procedural Data Collection for Continuous Improvement of the KODEX - EPD™ System Performance.
Recruiting NCT06073509 - Atrial Fibrillation and Other Cardiac Arrhythmias and Diseases After Radiotherapy for Breast Cancer : Watch Your HeaRT
Completed NCT04463524 - Screening for Hearth Rhythm Disorders
Withdrawn NCT01394965 - Electrocardiographic Mapping and Imaging Phase 0
Completed NCT01672528 - Patient Reported Outcome Measures for Ablation of Cardiac Arrhythmias
Completed NCT02232204 - Sleep and Ventricular Arrhythmias Study Phase 2
Completed NCT05114382 - An Evaluation of the Safety and Performance of the CathVision Cube® System N/A